E
E V Boyakova
Publications - 11
Citations - 173
E V Boyakova is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 4, co-authored 5 publications receiving 133 citations.
Papers
More filters
Journal ArticleDOI
TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
Michael Maschan,Larisa Shelikhova,Maria Ilushina,Elena Kurnikova,E V Boyakova,Dmitry Balashov,M.I. Persiantseva,Y.V. Skvortsova,Alexandra Laberko,Yakov Muzalevskii,Alexei Kazachenok,Svetlana Glushkova,Vlasta O. Bobrynina,V Kalinina,Y Olshanskaya,Dina Baidildina,G.A. Novichkova,Alexey Maschan +17 more
TL;DR: The data suggest that TCR-alpha/beta and CD19 depletion is a robust method of graft manipulation, which can be used to engineer grafts for children with high-risk AML.
Journal ArticleDOI
Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children.
Ivan V. Zvyagin,Ivan V. Zvyagin,Ilgar Z. Mamedov,Ilgar Z. Mamedov,O V Tatarinova,Ekaterina A. Komech,Elena Kurnikova,E V Boyakova,V.V. Brilliantova,Larisa Shelikhova,D.N. Balashov,Mikhail Shugay,Mikhail Shugay,Mikhail Shugay,Anastasiia L. Sycheva,Sofya A. Kasatskaya,Y B Lebedev,A. A. Maschan,Michael Maschan,Dmitry M. Chudakov,Dmitry M. Chudakov,Dmitry M. Chudakov +21 more
TL;DR: The results indicate that further efforts on optimization of TCRαβ-/CD19-depleted transplantation protocols should be directed toward providing more efficient T-cell defense in the first months after transplantation.
Journal ArticleDOI
Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF.
Alexey Maschan,Dmitry Balashov,Elena Kurnikova,Pavel Trakhtman,E V Boyakova,E V Skorobogatova,G.A. Novichkova,Michael Maschan +7 more
TL;DR: It is confirmed that plerixafor has impressive efficacy and very modest toxicity in children and in pediatric patients who failed to mobilize progenitors with G-CSF-based regimens.
Journal ArticleDOI
Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.
D A Shasheleva,Alexey Maschan,Larisa Shelikhova,U.N. Petrova,Elena Kurnikova,O I Illarionova,E V Boyakova,G.A. Novichkova,Michael Maschan +8 more
TL;DR: Transplantation of TCRalfa/beta and CD19 depleted hematopoietic cells from matched unrelated donor after immunoablative conditioning and supported with short course of eculizumab is perfectly safe and efficient technology leading to cure in young patients with PNH.
Journal ArticleDOI
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
Alexander Popov,Guenter Henze,Julia Roumiantseva,O.I. Budanov,Mikhail Belevtsev,Tatiana Verzhbitskaya,E V Boyakova,Liudmila Movchan,Grigory Tsaur,Maria S. Fadeeva,Svetlana Lagoyko,L. Zharikova,Natalia Miakova,Dmitry Litvinov,Olga Khlebnikova,Olga Streneva,E L Stolyarova,Natalia Ponomareva,Galina Novichkova,L Fechina,O.V. Aleinikova,Alexander Karachunskiy +21 more
TL;DR: A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy.